Literature DB >> 939922

Chemical and biological characterization of the lipopolysaccharide of Bacteroides fragilis subspecies fragilis.

D L Kasper.   

Abstract

Bacterial lipopolysaccharides extracted from Bacteroides fragilis subspecies fragilis lacked 2-keto-3-deoxyoctonate and heptose, sugars which make up part of the inner core of most bacterial endotoxins. Over 98% of the lipid portion of this material could be removed easily with chloroform-methanol and alcohol, a finding which indicates a loose association between the polysaccharide and lipid moieties. The lipopolysaccharides caused gelation of limulus lysate at a concentration significantly higher than that for the endotoxin of Salmonella typhi. None of the extracts was lethal in 10-day-old chick embryos at doses of greater than 200 mug per egg, whereas the endotoxin of Neisseria meningitidis was lethal at a dose of 1.2 mug per egg. The local Shwartzman reaction could not be induced by levels of B. fragilis endotoxin of up to 1,000 mug per rabbit, whereas a (control) endotoxin of S. typhi induced this phenomenon at a level of 3 mug per rabbit. Intact oxygen-killed B. fragilis failed to provoke the local Shwartzman reaction at doses of 2,500 mug. These results indicate that B. fragilis has a lipopolysaccharide different from that of most gram-negative bacteria. Although it retains some of the chemical and biologic properties of classical endotoxin, it seems to lack others. This observation may have significant clinical implications.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 939922     DOI: 10.1093/infdis/134.1.59

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  39 in total

1.  Macrolide accumulation by Bacteroides fragilis ATCC 25285.

Authors:  Y Muto; K Bandoh; K Watanabe; N Katoh; K Ueno
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

2.  Role of T lymphocytes in liver abscess formation by Bacteroides fragilis in mice.

Authors:  Doo Ryeon Chung; Hye-Rim Park; Chung-Gyu Park; Eung-Soo Hwang; Chang-Yong Cha
Journal:  Infect Immun       Date:  2011-03-28       Impact factor: 3.441

3.  Monoclonal antibodies to Bacteroides fragilis lipopolysaccharide.

Authors:  L Linko-Kettunen; P Arstila; M Jalkanen; H Jousimies-Somer; O Lassila; O P Lehtonen; A Weintraub; M K Viljanen
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

4.  The cell-surface antigens of Bacteroides thetaiotaomicron.

Authors:  F Meisel-Mikolajczyk; A Rokosz; W Kaca
Journal:  Eur J Epidemiol       Date:  1989-12       Impact factor: 8.082

5.  Commensal Microbiota Modulation of Natural Resistance to Virus Infection.

Authors:  Kailyn L Stefan; Myoungjoo V Kim; Akiko Iwasaki; Dennis L Kasper
Journal:  Cell       Date:  2020-11-18       Impact factor: 41.582

6.  Nature, type of linkage, quantity, and absolute configuration of (3-hydroxy) fatty acids in lipopolysaccharides from Bacteroides fragilis NCTC 9343 and related strains.

Authors:  H W Wollenweber; E T Rietschel; T Hofstad; A Weintraub; A A Lindberg
Journal:  J Bacteriol       Date:  1980-12       Impact factor: 3.490

7.  Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features.

Authors:  M Caroff; R Chaby; D Karibian; J Perry; C Deprun; L Szabó
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

8.  Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.

Authors:  A B Onderdonk; R B Markham; D F Zaleznik; R L Cisneros; D L Kasper
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

9.  Lipid A in anaerobic bacteria.

Authors:  G Dahlén; I Mattsby-Baltzer
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

10.  Relationships between serological groups and deoxyribonucleic acid homology groups in Bacteroides fragilis and related species.

Authors:  J L Babb; C S Cummings
Journal:  J Clin Microbiol       Date:  1981-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.